Peak Bio-Ignyte Acquisition IPO

Dongwon Group has canceled its bid to take over McDonald's franchise in South Korea."We reviewed the takeover of McDonald's Korea but our conclusion...

South Korean small- and medium-sized enterprises (SMEs) expanded their exchange and cooperation with US firms during President Yoon Suk yeol's state...

South Korean bio-regenerative medical firm CG Bio has launched a new US corporation CG MedTech, to focus on the development and marketing of tissue ...

Musinsa Co., South Korea’s leading online fashion platform, is in the final stage of attracting 200 billion won ($149.8 million) from US priva...

South Korea’s Lotte Biologics Co. said on Friday that it has made an equity investment in Pinotbio, Inc. for the development of antibody-drug ...

SK On Co., the world’s fifth-largest battery maker, is slated to attract 1.5 trillion won ($1.1 billion) from a consortium of US private equit...

South Korea’s Lotte Biologics Co. held a plaque ceremony on Monday to commemorate the acquisition of a pharmaceutical production plant from Br...

South Korea is set to introduce a system of cornerstone investors who agree in advance to subscribe to a forthcoming listing with conditions of lock...

South Korean anti-cancer immunotherapy company Vaxcell-Bio Therapeutics announced on Friday that its natural killer (NK) cell therapy, Vax-NK/HCC, h...

GS Entec Corp., a South Korean equipment maker for petrochemical and power plants, is set to raise 150 billion to 200 billion won ($115 million-$154...

South Korea's first-generation bio companies and Industrial Bank of Korea (IBK) have created a bio investment fund to support ventures in the field ...

The Korean Defense Acquisition Program Administration (DAPA) teams up with major US defense contractor Boeing to conduct research and development on...

LG Chem Ltd. has partnered with a US-based biofuel company Gevo to expand its bio-material-based plastic business.The company announced on Thursday ...

ASICLAND Co. is the only South Korean semiconductor design house for the world’s largest foundry TSMC Co., which manufactures chips for about ...

South Korea’s SK Biopharmaceuticals on Tuesday said two of its self-developed wearable devices won the main prize in the health care category ...

South Korea’s online retail platform Interpark Corp. has reported its airline ticket sales in March jumped 281% compared to the same period la...

Hanwha Solutions Corp., a South Korean petrochemical company, is partnering with domestic polyvinyl chloride (PVC) companies to promote the commerci...

Kyobo Life Insurance Co. has completed the process to put a South Korea-based alternative asset investment company under its wing, a move that is ex...

A management dispute over a South Korean pharmaceutical maker CTC Bio Inc. specializing in animal drugs is intensifying as another medical company h...

Around 200 South Korean ventures have debuted on the country’s secondary Kosdaq market through the technology special listing program since 20...

Kurly Inc., South Korea’s leading food delivery platform, has embarked on a new funding round to raise 100 billion won ($76 million) at about ...

South Korea’s energy storage devices maker LS Materials Co. began the process for an initial public offering later this year as it aims to dev...

Lotte Biologics, South Korea's biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Sunday that it has...

SK Innovation Co. is set to consider providing stocks of its electric vehicle battery subsidiary to its shareholders when SK On Co., the world&rsquo...

South Korea's Hanwha Life Insurance said on Thursday that it has acquired a 62.6% stake in Indonesian insurer Lippo General Insurance, in collaborat...

South Korean leading foundry chipmaker DB HiTek’s stock price hit a near 10-month high this week as a domestic activist fund bought a stake to...

LG Group Chairman Koo Kwang-mo has pledged to continue investing in future-oriented businesses and human resources despite the global economic slowd...

South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...

Kobiolabs Co., South Korea's new drug development company for microbiomes, announced on Tuesday that it has signed a memorandum of understanding for...

South Korean biosimilar giant Celltrion Group’s founder Seo Jung-jin has returned to management two years after his departure, pledging to mer...